All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

The Pharmacist’s Guide to Patient Identification, Testing, and Antiviral Use.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Ensuring Compliance in the Age of Antimicrobial Stewardship Regulation (BCIDP Activity)

 Purchase Activity (ACPE + BCIDP Credit), $75
SIDP Members
login to SIDP to verify your membership, then follow the members only link to receive discounts 
 ACPE + BCIDP $37.50


A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) 

 View more SIDPEC Activities

Activity Description

In 2014, President Obama signed an executive order triggering a cascade of activity meant to tackle the emerging threat of antimicrobial resistance. That executive order included the establishment of robust antimicrobial stewardship programs in hospitals. Since that time, major regulatory agencies have codified their expectations around antimicrobial stewardship in the acute care setting. This webinar will review the seminal role of the Center for Disease Control (CDC) Core Elements of Hospital Antimicrobial Stewardship Programs document and the expectations such programs as outlined by Centers for Medicare & Medicaid Services (CMS) and the Joint Commission (TJC). It will also elaborate how other entities, such as the National Healthcare Safety Network (NHSN), use antimicrobial stewardship as part of their assessment of a hospital’s overall quality activities.

Learning Objectives

The target audience for this activity includes pharmacists and board-certified infectious diseases pharmacists (BCIDPs). At the completion of this activity, the participant will be able to:

  • Describe some of the regulations and actions prompted by the PCAST (President’s Council of Advisors on Science and Technology) Report to the President on Combating Antibiotic Resistance.
  • Describe the conditions of participation for antimicrobial stewardship programs (ASPs) in acute care settings as delineated by Centers for Medicare & Medicaid Services (CMS).
  • Identify the requirements for ASPs in acute care settings as delineated by The Joint Commission (TJC).
  • Define the patient safety based requirements for ASPs in acute care settings as delineated by other regulatory/quality entities (i.e. National Healthcare Safety Network (NHSN), Leapfrog survey, etc).
  • Review questions related to antimicrobial stewardship (AS) that may be posed by a regulatory body during a survey.
  • Summarize interventions and processes that can be enacted in order to ensure compliance with regulatory requirements.


Keith Teelucksingh, Pharm.D., BCPS, BCIDP
Division Infectious Disease Pharmacist
HealthTrust Supply Chain
HCA South Atlantic Division, Charleston, SC

CE Accreditation

Release Date: August 18, 2020
Expiration Date: October 15, 2021


This activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-240-H04-P has been assigned to this home study, knowledge-based activity. This activity is approved for 1.5 contact hour (0.15 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test with a score of 70% or higher are required to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at, and proof of completion will be posted in NABP CPE Monitor profiles.


The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online upon successful completion of a post-test and online evaluation. The post-test must be successfully completed in only one attempt. No partial credit will be given. BCIDP accreditation begins 08/18/2020 for this activity and is available for one year from this date.

Recertification Criteria for Infectious Diseases Pharmacy: BCIDP recertifying via continuing education are required to earn 100 hours of continuing education credit provided by the joint program offered by the Society of Infectious Diseases Pharmacists (SIDP), the American College of Clinical Pharmacy (ACCP) and the American Society of Health-System Pharmacists (ASHP). Infectious Diseases Pharmacy Specialty Recertification Courses offered by any of the approved providers may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle. Candidates should note that there are expiration dates associated with earning BPS recertification credit. BPS will only award recertification credit for modules based on the completion and submission date of the post-test assessment. For example, a module completed and submitted on October 20 of a particular year will only be credited for that year, even if the due date of the post-test is in January of the following year. View all recertification criteria on the BPS website at


It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Keith Teelucksingh has no conflict of interest to report.


This activity is provided by ProCE, Inc. and SIDP.


The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.